Insider trades
George Kemble, Director of Sagimet Biosciences SGMT, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $289.8K. The latest trade was on 06/12.
George Kemble
Director
- Company
- Sagimet Biosciences SGMT
- First filing
- 23/07/20
- Trades
- 24 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- −$289.8K
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/11/20 | 25/11/21 | 37,688 sh | $7.69 | $289,820.72 | −31.8% | |
| Open-market sale10b5-1 plan | 24/07/23 | 24/07/25 | 23,625 sh | $3.17 | $74,891.25 | −16.6% | |
| Open-market sale | 24/07/19 | 24/07/23 | 14,062 sh | $3.10 | $43,592.2 | −9.0% |